Compliance with WHO mERA and CONSORT-EHEALTH in Randomized and Controlled Clinical Trials of Mobile App Interventions for Stroke Management

Submitted by: Dimeji Olawuyi
Dimeji Olawuyi (1,2,3), Oghenemaro Jerry-Ogeme (1,2,3), Muideen Yusuf (1,4), Blessed Olaomo (1,2,3), Gideon Olajide (1,2), Olasunkanmi Ogunbiyi (1,2), Rachel Dada (1,5), Hameedah Azeez (1,2)
1 Smilebuilders Initiative, Ibadan, Nigeria
2 College of Medicine, University of Ibadan, Ibadan, Nigeria
3 Federation of African Medical Students’ Associations, Ibadan, Nigeria
4 University College Hospital, Ibadan, Nigeria
5 Babcock University Teaching Hospital, Ogun State, Nigeria

Background

Mobile application interventions for stroke management are expanding, yet compliance with reporting guidelines remains unclear. This study aimed to evaluate the compliance of publications on mobile applications interventions for stroke management with the standard reporting guideline by the WHO (mERA) and the Consolidated Standards of Reporting Trials of Electronic and Mobile Health Applications and Online Telehealth (CONSORT-EHEALTH).

Methods

A review of literature was conducted in PubMed, EMBASE, Web of Science and Cochrane databases until May 2025. Randomized controlled trials or controlled clinical trials publications reporting mobile application interventions among stroke survivors and focused on medication adherence, functional outcomes, cardiovascular risk factors, quality of life, and knowledge of stroke were included. Two independent reviewers screened against eligibility criteria and the mERA and CONSORT-EHEALTH guidelines.

Results

28 studies (22 RCTs and 6 CCTs) were included. Most of the studies were conducted in South Korea (n = 7). Mean mERA compliance was 44.6% (18.8–75.0%) with intervention delivery (n=28) and technology platform (n=27) reported highest and cost assessment (n=2) and infrastructure (n=2) least reported. While mean CONSORT-EHEALTH compliance was 69.8% (59.4–81.0%) with no report of items 7b, 11b, 17b, 19, and 24 and less than 20% of the studies reported items 3b, 6b, 8b, 12b, 14b, and 18. RCTs showed slightly higher compliance than CCTs for both mERA (45.2% vs 42.7%) and CONSORT-EHEALTH (70.1% vs 68.6%). After 2016, mERA compliance increased to 47.4% (n=17) but declined to 41.3% (n=10) in 2021–2025. CONSORT-EHEALTH compliance remained high: 69.3% (2016–2020, n=17) and 70.7% (2021–2025, n=10). Regional analysis showed consistently higher CONSORT-EHEALTH compliance across all countries. Correlation between mERA and CONSORT-EHEALTH scores was weak (Pearson r = –0.09, p = 0.64).

Conclusion

Compliance with mERA and CONSORT-EHEALTH guidelines remains suboptimal. This emphasizes the urgent need to improve reporting quality in mobile health stroke trials.

Keywords: Stroke; Mobile App; mhealth; mERA; CONSORT-EHEALTH

Facebook
LinkedIn
X
Reddit
Email
WhatsApp
Digital Health Africa
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.